The Cbl interactome and its functions

Nature Reviews Molecular Cell Biology

Volumn 6, Issue 12, 2005, Pages 907-918

  Schmidt, Mirko H H ^a   Dikic, Ivan ^a,b  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

^b Mediterranean Institute for Life Sciences   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADAPTOR PROTEIN; CBL PROTEIN; LIGASE;

CANCER; CELL TYPE; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME REGULATION; HUMAN; IMMUNOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

ACTINS; ANIMALS; ENDOCYTOSIS; HUMANS; LYMPHOCYTES; MULTIPROTEIN COMPLEXES; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 28844490931     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm1762     Document Type: Review

References (123)

1. Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 103, 211-225 (2000).
2. Yarden, Y. & Sliwkowski, M. X. Untangling the ErbB signalling network. Nature Rev. Mol. Cell Biol. 2, 127-137 (2001).
3. Jordan, J. D., Landau, E. M. & Iyengar, R. Signaling networks: the origins of cellular multitasking. Cell 103, 193-200 (2000).
4. Hoeller, D., Volarevic, S. & Dikic, I. Compartmentalization of growth factor receptor signalling. Curr. Opin. Cell Biol. 17, 107-111 (2005).
5. Thien, C. B. & Langdon, W. Y. Cbl: many adaptations to regulate protein tyrosine kinases. Nature Rev. Mol. Cell Biol. 2, 294-307 (2001). An important review on Cbl proteins that provides details on their identification and their functions in tyrosine kinase signalling pathways.
6. Langdon, W. Y., Hartley, J. W., Klinken, S. P., Ruscetti, S. K. & Morse, H. C. 3rd. v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. Proc. Natl Acad. Sci. USA 86, 1168-1172 (1989).
7. Keane, M. M., Rivero-Lezcano, O. M., Mitchell, J. A., Robbins, K. C. & Lipkowitz, S. Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene. Oncogene 10, 2367-2377 (1995).
8. Keane, M. M. et al. Cbl-3: a new mammalian cbl family protein. Oncogene 18, 3365-3375 (1999).
9. Kim, M. et al. Molecular cloning and characterization of a nova cbl-family gene, cbl-c. Gene 239, 145-154 (1999).
10. Griffiths, E. K. et al. Cbl-3-deficient mice exhibit normal epithelial development. Mol. Cell. Biol. 23, 7708-7718 (2003).
11. Weissman, A. M. Themes and variations on ubiquitylation. Nature Rev. Mol. Cell Biol. 2, 169-178 (2001).
12. Ciechanover, A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nature Rev. Mol. Cell Biol. 6, 79-87 (2005).
13. Hicke, L. Protein regulation by monoubiquitin. Nature Rev. Mol. Cell Biol. 2, 195-201 (2001).
14. Di Fiore, P. P., Polo, S. & Hofmann, K. When ubiquitin meets ubiquitin receptors: a signalling connection. Nature Rev. Mol. Cell Biol. 4, 491-4197 (2003).
15. Dikic, I., Szymkiewicz, I. & Soubeyran, P. Cbl signaling networks in the regulation of cell function. Cell. Mol. Life Sci. 60, 1805-1827 (2003).
16. Tanaka, S., Neff, L., Baron, R. & Levy, J. B. Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways. J. Biol. Chem. 270, 14347-14351 (1995).
17. Galisteo, M. L., Dikic, I., Batzer, A. G., Langdon, W. Y. & Schlessinger, J. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation. J. Biol. Chem. 270, 20242-20245 (1995).
18. Bowtell, D. D. & Langdon, W. Y. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation. Oncogene 11, 1561-1567 (1995).
19. Meisner, H. & Czech, M. P. Coupling of the proto-oncogene product c-Cbl to the epidermal growth factor receptor. J. Biol. Chem. 270, 25332-25335 (1995).
20. Levkowitz, G. et al. Coupling of the c-Cbl proto-oncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins. Oncogene 12, 1117-1125 (1996).
21. Jongeward, G. D., Clandinin, T. R. & Sternberg, P. W. sli-1, a negative regulator of LET-23-mediated signaling in C. elegans. Genetics 139, 1553-1566 (1995).
22. Sternberg, P. W. et al. LET-23-mediated signal transduction during Caenorhabditis elegans development. Mol. Reprod. Dev. 42, 523-528 (1995).
23. Yoon, C. H., Lee, J., Jongeward, G. D. & Sternberg, P. W. Similarity of SLI-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl. Science 269, 1102-1105 (1995). Describes how the C. elegans orthologue of Cbl, SLI-1, negatively regulates functions of the EGFR orthologue, LET-23. This paper took the view on Cbl beyond the adaptor horizon.
24. Langdon, W. Y. The cbl oncogene: a novel substrate of protein tyrosine kinases. Aust. N. Z. J. Med. 25, 859-864 (1995).
25. Schlessinger, J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110, 669-672 (2002).
26. Jiang, X., Huang, F., Marusyk, A. & Sorkin, A. Grb2 regulates internalization of EGF receptors through clathrin-coated pits. Mol. Biol. Cell 14, 858-870 (2003).
27. Fukazawa, T., Miyake, S., Band, V. & Band, H. Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins. J. Biol. Chem. 271, 14554-14559 (1996).
28. Margolis, B. L. et al. All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor. J. Biol. Chem. 264, 10667-10671 (1989).
29. Grovdal, L. M., Stang, E., Sorkin, A. & Madshus, I. H. Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation. Exp. Cell Res. 300, 388-395 (2004).
30. Joazeiro, C. A. et al. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286, 309-312 (1999).
31. Levkowitz, G. et al. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol. Cell 4, 1029-1040 (1999). The studies in references 30 and 31 present the identification of Cbl as an ubiquitin-ligase for receptor tyrosine kinases.
32. Dikic, I. & Giordano, S. Negative receptor signalling. Curr. Opin Cell Biol. 15, 128-135 (2003).
33. Dikic, I. CIN85/CMS family of adaptor molecules. FEBS Lett. 529, 110-115 (2002).
34. Petrelli, A. et al. The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature 416, 187-190 (2002).
35. Soubeyran, P., Kowanetz, K., Szymkiewicz, I., Langdon, W. Y. & Dikic, I. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 416, 183-187 (2002). The studies in references 33 and 34 describe how Cbl mediates internalization of activated growth factor receptors independently of its ubiquitin ligase activity. Phosphorylated Cbl functions as an adaptor to recruit CIN85/endophilins into active receptor complexes and thereby promotes endocytosis of EGF and HGF receptors.
36. Lynch, D. K. et al. A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton. J. Biol. Chem. 278, 21805-21813 (2003).
37. Holler, D. & Dikic, I. Receptor endocytosis via ubiquitin-dependent and -independent pathways. Biochem. Pharmacol. 67, 1013-1017 (2004).
38. Sigismund, S. et al. From the cover: clathrin-independent endocytosis of ubiquitinated cargos. Proc. Natl Acad. Sci. USA 102, 2760-2765 (2005).
39. Duan, L. et al. Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis. J. Biol. Chem. 278, 28950-28960 (2003).
40. Simonsen, A., Wurmser, A. E., Emr, S. D. & Stenmark, H. The role of phosphoinositides in membrane transport. Curr. Opin Cell Biol. 13, 485-492 (2001).
41. Gout, I. et al. Negative regulation of Pl 3-kinase by Ruk, a novel adaptor protein. EMBO J. 19, 4015-4025 (2000).
42. Choi, J. H. et al. Cbl competitively inhibits epidermal growth factor-induced activation of phospholipase C-χ1. Mol. Cells 15, 245-255 (2003).
43. Raucher, D. et al. Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion. Cell 100, 221-228 (2000).
44. Kowanetz, K. et al. CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors. Mol. Biol. Cell 15, 3155-3166 (2004).
45. Stenmark, H. Cycling lipids. Curr. Biol. 10, R57-R59 (2000).
46. Zerial, M. & McBride, H. Rab proteins as membrane organizers. Nature Rev. Mol. Cell Biol. 2, 107-117 (2001).
47. Uddin, S., Gardziola, C., Dangat, A., Yi, T. & Platanias, L. C. Interaction of the c-cbl proto-oncogene product with the Tyk-2 protein tyrosine kinase. Biochem. Biophys. Res. Commun. 225, 833-838 (1996).
48. Magnifico, A. et al. WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J. Biol. Chem. 278, 43169-43177 (2003).
49. Bao, J., Gur, G. & Yarden, Y. Src promotes destruction of c-Cbl: implications for oncogenic synergy between Src and growth factor receptors. Proc. Natl Acad. Sci. USA 100, 2438-2443 (2003).
50. Yokouchi, M. et al. Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins. J. Biol. Chem. 276, 35185-35193 (2001).
51. Schmidt, M. H., Furnari, F. B., Cavenee, W. K. & Bogler, O. Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization. Proc. Natl Acad. Sci. USA 100, 6505-6510 (2003).
52. Kim, H. J. & Bar-Sagi, D. Modulation of signalling by Sprouty: a developing story. Nature Rev. Mol. Cell Biol. 5, 441-450 (2004).
53. Haglund, K., Schmidt, M. H., Wong, E. S., Guy, G. R. & Dikic, I. Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation. EMBO Rep. 6, 635-641 (2005).
54. Wu, W. J., Tu, S. & Cerione, R. A. Activated Cdc42 sequesters c-Cbl and prevents EGF receptor degradation. Cell 114, 715-725 (2003).
55. Kowanetz, K. et al. Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases. J. Biol. Chem. 279, 32786-32795 (2004).
56. Feshchenko, E. A. et al. TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin. Oncogene 23, 9449 (2004).
57. Carpino, N. et al. Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2. Immunity 20, 37-46 (2004).
58. Schmidt, M. H., Dikic, I. & Bogler, O. Src phosphorylation of Alix/AIP1 modulates its interaction with binding partners and antagonizes its activities. J. Biol. Chem. 280, 3414-3425 (2005).
59. Schmidt, M. H. et al. Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex. Mol. Cell Biol. 24, 8981-8993 (2004).
60. Strack, B., Calistri, A., Craig, S., Popova, E. & Gottlinger, H. G. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114, 689-699 (2003).
61. Lee, K. H. et al. The immunological synapse balances T cell receptor signaling and degradation. Science 302, 1218-1222 (2003).
62. Jun, J. E. & Goodnow, C. C. Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling. Nature Immunol. 4, 1057-1064 (2003).
63. Janssen, E. & Zhang, W. Adaptor proteins in lymphocyte activation. Curr. Opin. Immunol. 15, 269-276 (2003).
64. Tang, J., Sawasdikosol, S., Chang, J. H. & Burakoff, S. J. SLAP, a dimeric adapter protein, plays a functional role in T cell receptor signaling. Proc. Natl Acad. Sci. USA 96, 9775-9780 (1999).
65. Chu, J., Liu, Y., Koretzky, G. A. & Durden, D. L. SLP-76-Cbl-Grb2-Shc interactions in FcχRI signaling. Blood 92, 1697-1706 (1998).
66. Watanabe, S. et al. Characterization of the CIN85 adaptor protein and identification of components involved in CIN85 complexes. Biochem. Biophys. Res. Commun. 278, 167-174 (2000).
67. Bonita, D. P., Miyake, S., Lupher, M. L., Jr., Langdon, W. Y. & Band, H. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor α signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity. Mol. Cell Biol. 17, 4597-4610 (1997).
68. Kong, G. et al. Distinct tyrosine phosphorylation sites in ZAP-70 mediate activation and negative regulation of antigen receptor function. Mol. Cell Biol. 16, 5026-5035 (1996).
69. Rao, N. et al. The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation. EMBO J. 20, 7085-7095 (2001).
70. Sohn, H. W., Gu, H. & Pierce, S. K. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk. J. Exp. Med. 197, 1511-1524 (2003).
71. Wang, H. Y. et al. Cbl promotes ubiquitination of the T cell receptor zeta through an adaptor function of Zap-70. J. Biol. Chem. 276, 26004-26011 (2001).
72. Liu, Y. et al. Protein kinase C activation inhibits tyrosine phosphorylation of Cbl and its recruitment of Src homology 2 domain-containing proteins. J. Immunol. 162, 7095-7101 (1999).
73. Fang, D. et al. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells. J. Biol. Chem. 276, 4872-4878 (2001).
74. -/- T cells inhibits downmodulation of surface T-cell receptors after ligand engagement, indicating that Cbl proteins negatively regulate T-cell activation.
75. Murphy, M. A. et al. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol. Cell Biol. 18, 4872-4882 (1998).
76. Naramura, M., Kole, H. K., Hu, R. J. & Gu, H. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc. Natl Acad. Sci. USA 95, 15547-15552 (1998).
77. Bachmaier, K. et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403, 211-216 (2000).
78. Chiang, Y. J. et al. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403, 216-220 (2000).
79. Thien, C. B. et al. A mouse with a loss-of-function mutation in the c-Cbl TKB domain shows perturbed thymocyte signaling without enhancing the activity of the ZAP-70 tyrosine kinase. J. Exp. Med. 197, 503-513 (2003).
80. Krawczyk, C. et al. Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells. Immunity 13, 463-473 (2000).
81. Krawczyk, C. & Penninger, J. M. Molecular controls of antigen receptor clustering and autoimmunity. Trends Cell Biol. 11, 212-220 (2001).
82. Graham, L. J. et al. 70Z/3 Cbl induces PLC χ1 activation in T lymphocytes via an alternate Lat- and Slp-76-independent signaling mechanism. Oncogene 22, 2493-2503 (2003).
83. Yasuda, T. et al. Cbl suppresses B cell receptor-mediated phospholipase C (PLC)-χ2 activation by regulating B cell linker protein-PLC-χ2 binding. J. Exp. Med. 191, 641-650 (2000).
84. Yasuda, T. et al. Cbl-b positively regulates Btk-mediated activation of phospholipase C-χ2 in B cells. J. Exp. Med. 196, 51-63 (2002).
85. Mueller, D. L. E3 ubiquitin ligases as T cell anergy factors. Nature Immunol. 5, 883-890 (2004).
86. Jeon, M. S. et al. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21, 167-177 (2004).
87. Liu, Y. C. et al. Serine phosphorylation of Cbl induced by phorbol ester enhances its association with 14-3-3 proteins in T cells via a novel serine-rich 14-3-3-binding motif. J. Biol. Chem. 272, 9979-9985 (1997).
88. Irvine, R. F. 20 years of Ins(1,4,5)P3, and 40 years before. Nature Rev. Mol. Cell Biol. 4, 586-590 (2003).
89. Irvine, R. F. Nuclear lipid signalling. Nature Rev. Mol. Cell Biol. 4, 349-360 (2003).
90. Davies, G. C. et al. Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b. Oncogene 23, 7104-7115 (2004).
91. Scaife, R. M. & Langdon, W. Y. c-Cbl localizes to actin lamellae and regulates lamellipodia formation and cell morphology. J. Cell Sci. 113, 215-226 (2000).
92. Scaife, R. M., Courtneidge, S. A. & Langdon, W. Y. The multi-adaptor proto-oncoprotein Cbl is a key regulator of Rac and actin assembly. J. Cell Sci. 116, 463-473 (2003).
93. Fernandez, J. A. et al. Phosphorylation- and activation-independent association of the tyrosine kinase Syk and the tyrosine kinase substrates Cbl and Vav with tubulin in B-cells. J. Biol. Chem. 274, 1401-1406 (1999).
94. Scaife, R. M., Job, D. & Langdon, W. Y. Rapid microtubule-dependent induction of neurite-like extensions in NIH 3T3 fibroblasts by inhibition of ROCK and Cbl. Mol. Biol. Cell 14, 4605-4617 (2003).
95. Gruenberg, J. & Stenmark, H. The biogenesis of multivesicular endosomes. Nature Rev. Mol. Cell Biol. 5, 317-323 (2004).
96. Ojaniemi, M., Martin, S. S., Dolfi, F., Olefsky J. M. & Vuori, K. The proto-oncogene product p120(cbl) links c-Src and phosphatidylinositol 3′-kinase to the integrin signaling pathway. J. Biol. Chem. 272, 3780-3787 (1997).
97. Manie, S. N. et al. Tyrosine phosphorylation of the product of the c-cbl protooncogene is induced after integrin stimulation. Exp. Hematol. 25, 45-50 (1997).
98. Zell, T. et al. Regulation of β 1-integrin-mediated cell adhesion by the Cbl adaptor protein. Curr. Biol. 8, 814-822 (1998).
99. Meng, F. & Lowell, C. A. A β1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration. EMBO J. 17, 4391-4403 (1998).
100. Tanaka, S. et al. c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Nature 383, 528-531 (1996).
101. Deckert, M., Elly, C., Altman, A. & Liu, Y. C. Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases. J. Biol. Chem. 273, 8867-8874 (1998).
102. Feshchenko, E. A., Langdon, W. Y. & Tsygankov, A. Y. Fyn, Yes, and Syk phosphorylation sites in c-Cbl map to the same tyrosine residues that become phosphorylated in activated T cells. J. Biol. Chem. 273, 8323-8331 (1998).
103. Tezuka, T. et al. Physical and functional association of the cbl protooncogen product with an src-family protein tyrosine kinase, p53/56lyn, in the B cell antigen receptor-mediated signaling. J. Exp. Med. 183, 675-680 (1996).
104. Miura-Shimura, Y. et al. Cbl-mediated ubiquitinylation and negative regulation of Vav. J. Biol. Chem. 278, 38495-38504 (2003).
105. Liu, J., Kimura, A., Baumann, C. A. & Saltiel, A. R. APS facilitates c-Cbl tyrosine phosphorylation and GLUT4 translocation in response to insulin in 3T3-L1 adipocytes. Mol. Cell Biol. 22, 3599-3609 (2002).
106. Standaert, M. L., Sajan, M. P., Miura, A., Bandyopadhyay, G. & Farese, R. V. Requirements for pYXXM motifs in Cbl for binding to the p85 subunit of phosphatidylinositol 3-kinase and Crk, and activation of atypical protein kinase C and glucose transport during insulin action in 3T3/L1 adipocytes. Biochemistry 43, 15494-15502 (2004).
107. Miura, A. et al. Cbl PYXXM motifs activate the P85 subunit of phosphatidylinositol 3-kinase, Crk, atypical protein kinase C, and glucose transport during thiazolidinedione action in 3T3/L1 and human adipocytes. Biochemistry 42, 14335-14341 (2003).
108. Ribon, V., Herrera, R., Kay B. K. & Saltiel, A. R. A role for CAP, a novel, multifunctional Src homology 3 domain-containing protein in formation of actin stress fibers and focal adhesions. J. Biol. Chem. 273, 4073-4080 (1998).
109. Soubeyran, P., Barac, A., Szymkiewicz, I. & Dikic, I. Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl. Biochem. J. 370, 29-34 (2003).
110. Schmidt, M. H., Chen, B., Randazzo, L. M. & Bogler, O. SETA/CIN85/Ruk and its binding partner AIP1 associate with diverse cytoskeletal elements, including FAKs, and modulate cell adhesion. J. Cell Sci. 116, 2845-2855 (2003).
111. Kirsch, K. H. et al. The adapter type protein CMS/CD2AP binds to the proto-oncogen ic protein c-Cbl through a tyrosine phosphorylation-regulated Src homology 3 domain interaction. J. Biol. Chem. 276, 4957-4963 (2001).
112. Haglund, K., Ivankovic-Dikic, I., Shimokawa, N., Kruh, G. D. & Dikic, I. Recruitment of Pyk2 and Cbl to lipid rafts mediates signals important for actin reorganization in growing neurites. J. Cell Sci. 117, 2557-2568 (2004).
113. Polte, T. R. & Hanks, S. K. Complexes of focal adhesion kinase (FAK) and Crk-associated substrate (p130(Cas)) are elevated in cytoskeleton-associated fractions following adhesion and Src transformation. Requirements for Src kinase activity and FAK proline-rich motifs. J. Biol. Chem. 272, 5501-5509 (1997).
114. 3 integrin-mediated signaling, cell adhesion, and osteoclast motility. J. Cell Biol. 152, 181-195 (2001).
115. Frame, M. C. Newest findings on the oldest oncogene; how activated src does it. J. Cell Sci. 117, 989-998 (2004).
116. Salgia, R., Sattler, M., Pisick, E., Li, J. L. & Griffin, J. D. p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl. Exp. Hematol. 24, 310-313 (1996).
117. Gotoh, T. et al. Activation of R-Ras by Ras-guanine nucleotide-releasing factor. J. Biol. Chem. 272, 18602-18607 (1997).
118. Chiang, S. H. et al. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 410, 944-948 (2001). Shows how Cbl and its interacting partners can regulate translocation of GLUT4.
119. Kanzaki, M. & Pessin, J. E. Insulin-stimulated GLUT4 translocation in adipocytes is dependent upon cortical actin remodeling. J. Biol. Chem. 276, 42436-42444 (2001).
120. Pickart, C. M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503-533 (2001).
121. Amit, I. et al. Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding. Genes Dev. 18, 1737-1752 (2004).
122. Breitkreutz, B. J., Stark, C. & Tyers, M. The GRID: the general repository for interaction datasets. Genome Biol. 4, R23 (2003).
123. Breitkreutz, B. J., Stark, C. & Tyers, M. Osprey: a network visualization system. Genome Biol. 4, R22 (2003).